Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Remitly Global Inc (RELY) vs Tempus AI (TEM) Price & Performance

Remitly Global IncTrade

Price performance (Past 24H)

Key statistics

Remitly Global Inc vs Tempus AI — how do they compare? Remitly Global Inc trades at $24.1 (market cap $5.26B), while Tempus AI trades at $61.25 (market cap $11.67B). The key difference: Tempus AI is far larger — about 2.2× Remitly Global Inc's market cap, and Remitly Global Inc is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals.

RELYTEM
Market Cap
$5.26B$11.67B
Sector
TechnologyBroad Market / Factor
52-Week High
$26.92$103.25
52-Week Low
$12.20$41.55
Enterprise Value
$4.62B$12.30B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Remitly Global Inc

RELY trades at $24.83, down 5.12% over 24 hours, with a bearish technical signal but strong fundamentals. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $0.93 significantly exceeding expectations of $0.12. Revenue growth is accelerating, reaching $1.64 billion in 2025, with net income turning positive at $67.93 million. A recent partnership with Etsy expands its payment provider reach, signaling business expansion. Analyst consensus is overwhelmingly bullish with a $31.17 price target, representing 25.5% upside from current levels.

The outlook for RELY is positive given its strong revenue trajectory, improving profitability, and strategic partnerships. Key opportunities include continued market share gains in digital remittances and new monetization avenues. Risks involve competitive pressures in fintech, reliance on economic conditions affecting remittance volumes, and potential volatility despite institutional backing. The stock's current pullback may offer a entry point, but investors should weigh execution risks against growth potential.

Tempus AI

Tempus AI (TEM) trades at $64.29, down 0.51% on the day, with a bullish technical signal and strong analyst support. The stock shows consistent earnings beats despite negative profitability, with a P/S of 7.99 and P/B of 26.23. Recent catalysts include FDA clearance for an AI ECG product and a $9.5 million ARPA-H award for autonomous AI in cardiology (Business Wire, September 9, 2026).

Outlook remains positive given analyst consensus and growth in precision medicine, but risks include sustained losses, high valuation multiples, and cash burn. The consensus price target is $69.11, implying potential upside, though investors must weigh the company's unprofitability against its innovation pipeline and market position.

Returns comparison

Trailing returns across standard periods

About Remitly Global Inc

Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. Its revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.

Read more on RELY

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Read more on TEM